Corvus Pharmaceuticals Ownership | Who Owns Corvus Pharmaceuticals?
Corvus Pharmaceuticals Ownership Summary
Corvus Pharmaceuticals is owned by 53.70% institutional investors, 3.96% insiders, and 42.34% retail investors. Orbimed advisors is the largest institutional shareholder, holding 9.21% of CRVS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.42% of its assets in Corvus Pharmaceuticals shares.
CRVS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Corvus Pharmaceuticals | 53.70% | 3.96% | 42.34% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 7.17M | 9.21% | $28.66M |
| Point72 asset management | 7.04M | 9.05% | $28.17M |
| Blackrock funding, inc. /de | 4.24M | 5.45% | $16.95M |
| Adams street partners | 3.28M | 4.21% | $13.10M |
| Vanguard group | 2.45M | 3.68% | $13.13M |
| Rtw investments, lp | 2.68M | 3.45% | $10.72M |
| Vivo capital | 2.23M | 2.87% | $8.94M |
| Foresite capital management vi | 1.73M | 2.23% | $6.92M |
| Perceptive advisors | 1.44M | 1.85% | $5.75M |
| Susquehanna group, llp | 1.02M | 1.52% | $5.43M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Adams street partners | 3.28M | 9.23% | $13.10M |
| Foresite capital management vi | 1.73M | 3.89% | $6.92M |
| Dcf advisers | 757.50K | 1.40% | $3.03M |
| Vivo capital | 2.23M | 0.91% | $8.94M |
| Orbimed advisors | 7.17M | 0.72% | $28.66M |
| Bml capital management | 118.77K | 0.36% | $475.06K |
| Towerview | 77.50K | 0.30% | $414.63K |
| Perceptive advisors | 1.44M | 0.21% | $5.75M |
| Sphera funds management | 183.09K | 0.17% | $732.38K |
| Rtw investments, lp | 2.68M | 0.15% | $10.72M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 7.04M | 0.06% | 4.25M |
| Blackrock funding, inc. /de | 4.24M | 0.00% | 3.18M |
| Perceptive advisors | 1.44M | 0.21% | 1.44M |
| Susquehanna group, llp | 1.02M | 0.00% | 796.12K |
| Dcf advisers | 757.50K | 1.40% | 357.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Samlyn capital | - | - | -4.07M |
| Deerfield management company, l.p. (series c) | - | - | -1.00M |
| Qube research | 43.97K | 0.00% | -405.11K |
| Bvf inc/il | - | - | -361.41K |
| Exoduspoint capital management, lp | - | - | -199.36K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Perceptive advisors | 1.44M | 0.21% | 1.44M | $5.75M |
| Empirical financial services, llc d.b.a. empirical wealth management | 168.00K | 0.02% | 168.00K | $672.00K |
| Bml capital management | 118.77K | 0.36% | 118.77K | $475.06K |
| Barclays | 106.02K | 0.00% | 106.02K | $567.00K |
| Argent advisors | 30.00K | 0.04% | 30.00K | $120.00K |
Sold Out
| Holder | Change |
|---|---|
| Parallel advisors | -20.00 |
| Ifp advisors | -24.00 |
| Eversource wealth advisors | -60.00 |
| Ica group wealth management | -165.00 |
| Signaturefd | -224.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 99 | -4.81% | 41,766,678 | 15.16% | 53 | 2.12% | 63 | 61.54% | 13 | -55.17% |
| Mar 31, 2025 | 104 | 2.97% | 36,268,523 | -3.73% | 50 | 1.58% | 40 | -41.18% | 29 | 190.00% |
| Dec 31, 2024 | 100 | 38.89% | 37,670,552 | 25.42% | 56 | 2.79% | 67 | 71.79% | 10 | - |
| Sep 30, 2024 | 70 | 40.00% | 30,020,596 | 8.80% | 45 | 1.42% | 38 | 100.00% | 10 | - |
| Jun 30, 2024 | 50 | - | 27,591,708 | 54.15% | 56 | 4.22% | 19 | - | 10 | -23.08% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.80M | 2.42% | -39.82K |
| Vanguard US Total Market Shares ETF | 1.58M | 2.32% | - |
| iShares Russell 2000 ETF | 1.23M | 1.60% | -23.41K |
| Vanguard Institutional Extnd Mkt Idx Tr | 677.67K | 0.91% | -308.80K |
| Fidelity Small Cap Index | 524.57K | 0.70% | 524.57K |
| iShares Russell 2000 Growth ETF | 453.70K | 0.59% | - |
| Fidelity Extended Market Index | 334.77K | 0.43% | 54.24K |
| iShares Biotechnology ETF | 324.62K | 0.42% | 2.77K |
| Vanguard Russell 2000 ETF | 249.45K | 0.33% | -17.18K |
| State St Russell Sm Cap® Indx SL Cl I | 184.80K | 0.24% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 27, 2025 | ORBIMED ADVISORS LLC | Sell | $4.89M | |
| Jun 27, 2025 | Thompson Peter A. | Sell | $4.89M | |
| May 06, 2024 | Thompson Peter A. | Buy | $144.41 | |
| May 06, 2024 | Thompson Peter A. | Buy | $4.89M | |
| May 06, 2024 | ORBIMED ADVISORS LLC | Buy | $144.41 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2024 Q4 | - | - |
| 2024 Q2 | 8 | - |
| 2024 Q1 | - | - |
| 2023 Q4 | - | - |
CRVS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools